Mark N. Lampert

Sits on 4 boards. Last updated September 28, 2026

Time on boards

Boards served
4
Current seats
4
Board service
11 years
Director since
2023

11 years of board service in total across 4 boards, counting each seat separately. Longest: Kymera Therapeutics Inc., 3 years.

3 years · Since 2023
3 years · Since 2023
3 years · Since 2023
Immunic Inc. Director
9 months · Since 2026

Insider trades

All notable trades →

From SEC Forms 4 and 5. Open-market purchases and sales are highlighted; grants, option exercises and shares withheld for tax are routine.

Date Company Transaction Shares Price Value
Mar 31, 2026 MoonLake Immunotherapeutics Open-market sale −1,932,354 $16.79 $32,444,224
Mar 31, 2026 MoonLake Immunotherapeutics Open-market sale −1,569,116 $16.79 $26,345,458
Mar 31, 2026 MoonLake Immunotherapeutics Open-market sale −248,530 $16.79 $4,172,819

Questions about Mark N. Lampert

What boards is Mark N. Lampert on?

Mark N. Lampert sits on the boards of Immunic Inc., Kymera Therapeutics Inc., MoonLake Immunotherapeutics and Olema Pharmaceuticals Inc.

How long has Mark N. Lampert served on boards?

Our records show at least 11 years of board service across 4 boards, the earliest from 2023.

Reviews (0)

Sign in to write a review.

No reviews yet. Be the first to write one.

We use cookies to run this site and, with your permission, to measure traffic and support the affiliate links that help fund it.